Evidence map›Paper›PMID 37206259›Full record

ArticleEJHaem2023

Acquired hemophilia A (AHA) due to anti-SARS-CoV-2 vaccination: A systematic review.

Fnu Amisha, Prachi Saluja, Paras Malik, Frits Van Rhee

Open access · diamondAbstract read
In one paragraph

Article in EJHaem, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Fnu AmishaDepartment of Internal Medicine University of Arkansas for Medical Sciences Little Rock Arkansas USA.ORCID https://orcid.org/0000-0002-5110-3443
Prachi SalujaDepartment of Internal Medicine University of Arkansas for Medical Sciences Little Rock Arkansas USA.
Paras MalikDepartment of Internal Medicine Jacobi Medical Center-Albert Einstein College of Medicine Bronx New York USA.
Frits Van RheeDivision of Hematology/Oncology Department of Internal Medicine University of Arkansas for Medical Sciences Little Rock Arkansas USA.
University of Arkansas for Medical Sciences · USAlbert Einstein College of Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccination against SARS-CoV2 has been the largest vaccination campaign over the past two decades. The aim of this study is to qualitatively assess the reported cases of acquired hemophilia A (AHA) that developed after COVID-19 vaccination to further elaborate on incidence, presentation, treatment, and outcomes.We queried Medline (PubMed), Google Scholar, and Embase databases to find reported cases of AHA after COVID-19 vaccines. We found 14 studies (19 cases) for this descriptive analysis. Most patients were elderly (mean age 73 years) and males (

Indexed as

acquired hemophilia AAHABNT162b2 vaccineCOVID‐19 vaccinemRNA‐1273 vaccine

Identifiers

PMID37206259
PMCPMC10188482
OpenAlexW4323925197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.